Evidence-Based Complementary and Alternative Medicine

Integrative Oncology


Publishing date
25 Oct 2013
Status
Published
Submission deadline
07 Jun 2013

Lead Editor

1University of Duisburg-Essen, Essen, Germany

2University of Kansas Cancer Center, Kansas City, KS, USA

3Institute for Social Medicine, Epidemiology and Health Economics, Charité University Medical Center, Berlin, Germany

4Department of General Oncology and the Integrative Medicine Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA


Integrative Oncology

Description

Complementary treatment approaches are increasingly requested by cancer patients and survivors to reduce side effects of conventional cancer treatment and enhance health-related quality of life. As many patients do not disclose their complementary therapies use to their oncologist, treatment plans are often not coordinated. Thus, the risk of adverse events and interactions of complementary with conventional therapies is increased. An informed alliance of conventional and complementary treatment providers is important to optimize health outcomes and safety.

Integrative Oncology that combines conventional cancer treatment with evidence-based complementary therapies and mind/body medicine has become a growing field of health care that strives to serve this demand. In Integrative Oncology, conventional and complementary approaches are joined in a way that aims to optimize outcomes and prevent adverse events.

While the evidence for both conventional and complementary cancer treatments is increasing, only few studies have explicitly encountered an integrative viewpoint. The implementation of Integrative Oncology practice guidelines in 2007 (updated in 2009) has been an important milestone; however, more research is needed that investigates effectiveness, safety, and optimal design of Integrative Oncology interventions.

This special issue is dedicated to research that focuses on Integrative Oncology interventions that combine conventional and complementary approaches to optimize patients' health outcomes. Both original research and high-quality systematic reviews are welcome. Potential topics include, but are not limited to:

  • Conception, implementation process, and evaluation of Integrative Oncology programs
  • Clinical trials of complementary therapies and/or mind/body medicine either alone or combined with conventional treatment
  • Complementary approaches for managing side effects of cancer and/or conventional cancer treatment
  • Interactions of complementary with conventional therapies
  • Basic research on mechanisms and models of Integrative Oncology
  • Patients' perceptions of Integrative Oncology programs

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/ecam/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/ecam/oncol/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2013
  • - Article ID 124032
  • - Editorial

Integrative Oncology

Gustav Dobos | Holger Cramer | ... | Lorenzo Cohen
  • Special Issue
  • - Volume 2013
  • - Article ID 789263
  • - Research Article

Chimonanthus nitens var. salicifolius Aqueous Extract Protects against 5-Fluorouracil Induced Gastrointestinal Mucositis in a Mouse Model

Zhenze Liu | Jun Xi | ... | Jian Fei
  • Special Issue
  • - Volume 2013
  • - Article ID 383142
  • - Review Article

Integrative Oncology: Best of Both Worlds—Theoretical, Practical, and Research Issues

Holger Cramer | Lorenzo Cohen | ... | Claudia M. Witt
  • Special Issue
  • - Volume 2013
  • - Article ID 527163
  • - Research Article

Complementary and Alternative Medicine: A Survey of Its Use in Pediatric Oncology

Rafiaa Valji | Denise Adams | ... | Sunita Vohra
  • Special Issue
  • - Volume 2013
  • - Article ID 454783
  • - Research Article

Synergistic Inhibition of Angiogenesis by Artesunate and Captopril In Vitro and In Vivo

Benjamin Krusche | Joachim Arend | Thomas Efferth
  • Special Issue
  • - Volume 2013
  • - Article ID 851256
  • - Research Article

A Study on the Mechanism of Cinobufagin in the Treatment of Paw Cancer Pain by Modulating Local β-Endorphin Expression In Vivo

Tao Chen | Wei Hu | ... | Ling Zhan
  • Special Issue
  • - Volume 2013
  • - Article ID 285903
  • - Research Article

Cytotoxicity and Modes of Action of the Methanol Extracts of Six Cameroonian Medicinal Plants against Multidrug-Resistant Tumor Cells

Victor Kuete | Aimé G. Fankam | ... | Thomas Efferth
  • Special Issue
  • - Volume 2013
  • - Article ID 165891
  • - Research Article

Exploring the Needs and Concerns of Women with Early Breast Cancer during Chemotherapy: Valued Outcomes during a Course of Traditional Acupuncture

S. Price | A. F. Long | M. Godfrey
  • Special Issue
  • - Volume 2013
  • - Article ID 632351
  • - Research Article

CAM and Pediatric Oncology: Where Are All the Best Cases?

Denise Adams | Courtney Spelliscy | ... | Sunita Vohra
  • Special Issue
  • - Volume 2013
  • - Article ID 301549
  • - Research Article

Use of Self-Care and Practitioner-Based Forms of Complementary and Alternative Medicine before and after a Diagnosis of Breast Cancer

Alissa R. Link | Marilie D. Gammon | ... | Heather Greenlee
Evidence-Based Complementary and Alternative Medicine
 Journal metrics
Acceptance rate26%
Submission to final decision70 days
Acceptance to publication39 days
CiteScore2.010
Impact Factor1.984
 Submit

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.